Latest filing published 01 Dec 2021 for Modus Therapeutics Holding AB, €1,311.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Claes Lindblad: trading record in brief
Claes Lindblad appears in our data through filings on Modus Therapeutics Holding AB shares, published by Finansinspektionen. In total, 3 filings cover trades dated from 20 July 2021 to 1 December 2021.
The open-market record is one-sided, with 2 purchases worth €7,456 and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The record was last updated on 1 December 2021 with an open-market purchase (€1,311) in Modus Therapeutics Holding AB. Publication is fast: at least half of the trades appear on Finansinspektionen on the same day. For comparison, MAR article 19 gives managers three business days to notify a trade. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Claes Lindblad
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,000 shares@ SEK 4.4710.6% of flowAktieISIN SE0015987904FI:csv-9fec446bc1390e22428fCanonical exit: 1 Mar 2022 (T+90)
- 7,812 shares@ SEK 6.4039.5% of flowBTU (betald tecknad unit)ISIN SE0015987904FI:csv-c51af236dc2b3f59b98f
- 86,000 shares@ SEK 0.732749.8% of flowWarrantFI:csv-11d95602dee17e9098e4Canonical exit: 18 Oct 2021 (T+90)
3 of 3 declarations